PD40-07 CLINICAL OUTCOMES AND ADVERSE EVENTS AFTER FIRST-LINE TREATMENT IN METASTATIC RENAL CELL CARCINOMA: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

Published on Sep 21, 2021in The Journal of Urology5.925
· DOI :10.1097/JU.0000000000002252
Felix K.-H. Chun69
Estimated H-index: 69
,
Alberto Briganti96
Estimated H-index: 96
(UniSR: Vita-Salute San Raffaele University)
+ 17 AuthorsAly-Khan A. Lalani12
Estimated H-index: 12
(McMaster University)
Source
Abstract
INTRODUCTION AND OBJECTIVE:Four recent first line clinical trials that leverage immune-oncology agents have demonstrated an overall survival benefit relative to sunitinib. However, formal network m...
References0
Newest
Cited By0
Newest